Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hye‐Jin Kim
Observed name:
Hye-Jin Kim
Institutions:
Korea National Institute of Health,
Korea Disease Control and Prevention Agency
Observed institutions:
Korea National Institute of Health,
Korea Disease Control and Prevention Agency
ORCID:
0000-0002-3474-7503
Observed ORCID:
0000-0002-3474-7503
OpenAlex ID:
A5013075455
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity
2023
·
Jinyoung Yang
, Hye‐Jin Kim
, et al.
·
Journal of Medical Virology
·
8
Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts
2025
·
Hyun Myung Kang
, Ho Jun Lee
, et al.
·
Journal of Infection and Public Health
·
5
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS‐CoV‐2 Omicron BA.1 and BA.5 variants
2023
·
Beomki Lee
, Jae‐Hoon Ko
, et al.
·
Journal of Medical Virology
·
5
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study
2024
·
Hyun Myung Kang
, Hye-Jin Kim
, et al.
·
The Journal of Infectious Diseases
·
4
Robust neutralization of emerging JN.1 subvariants by the updated JN.1 vaccine: rationale for catch-up booster recommendations in high-risk individuals
2026
·
Ju-yeon Choi
, Su-Hwan Kim
, et al.
·
Frontiers in Immunology
·
1
PDF
Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea
2023
·
Hye-Jin Kim
, Jieun Kim
, et al.
·
Osong Public Health and Research Perspectives
·
1
Show more works
View as search
Works count:
6
Citation count:
24
H-index:
4
I10-index:
Year
Topic
Type